CYTOMED THERAPEUTICS LIMITED
Country of registration | Singapore |
Registration number | 201808327H |
Local SIC | |
Incorporation date | 9 Mar 2018 |
Company age | 8 years 3 months |
Official entity type | Public Company Limited By Shares |
No. of officers | 29 |
Contact
1 COMMONWEALTH LANE, #08-22, ONE COMMONWEALTH, Singapore 149544
This is the legal entity page of CYTOMED THERAPEUTICS LIMITED. To access company info, company size, news , key makers’ emails, visit the profile pages above.
- CYTOMED THERAPEUTICS LIMITEDView MoreSingaporeCytoMed is a biopharmaceutical company founded in 2018, spinning off from A*STAR, Singapore's national research and development agency. Our mission is to leverage our licensed proprietary technologies to develop novel cell-based immunotherapies for the treatment of human cancers, with a focus on overcoming current clinical limitations and commercial challenges in treating solid tumors, building upon the successful clinical outcomes of CAR-T in hematological malignancies.
Auditor | KE TRUST PAC |
Revenue | > 10m |
Share Capital - Ordinary shares | USD 10,768,187 |
Share Capital - Ordinary shares | SGD 9,163,005 |
Frequently Asked Questions (FAQ)
- What is the address of CYTOMED THERAPEUTICS LIMITED?
- Where is CYTOMED THERAPEUTICS LIMITED's headquarter?
- What is CYTOMED THERAPEUTICS LIMITED's contact number?
- What CYTOMED THERAPEUTICS LIMITED's spending power?
- Does CYTOMED THERAPEUTICS LIMITED have a presence in the domain it operates in?

